Axsome Therapeutics shares owned by Rhumbline Advisers
Quarter-by-quarter ownership of Axsome Therapeutics (AXSM) shares owned by Rhumbline Advisers
from 13F filings
Historical chart of Rhumbline Advisers investment in Axsome Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Axsome Therapeutics held by Rhumbline Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Axsome Therapeutics by Rhumbline Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.4M | 61k | 121.45 |
| 2025-06-30 | $6.5M | 62k | 104.39 |
| 2025-03-31 | $6.4M | 55k | 116.63 |
| 2024-12-31 | $4.3M | 51k | 84.61 |
| 2024-09-30 | $4.6M | 51k | 89.87 |
| 2024-06-30 | $4.4M | 55k | 80.50 |
| 2024-03-31 | $4.2M | 52k | 79.80 |
| 2023-12-31 | $4.0M | 51k | 79.59 |
| 2023-09-30 | $3.6M | 51k | 69.89 |
| 2023-06-30 | $3.4M | 47k | 71.86 |
| 2023-03-31 | $2.7M | 44k | 61.69 |
| 2022-12-31 | $3.3M | 43k | 77.13 |
| 2022-09-30 | $1.7M | 39k | 44.63 |
| 2022-06-30 | $1.3M | 35k | 38.31 |
| 2022-03-31 | $1.2M | 29k | 41.40 |
| 2021-12-31 | $1.1M | 30k | 37.79 |
| 2021-09-30 | $986k | 30k | 32.94 |
| 2021-06-30 | $2.0M | 30k | 67.45 |
| 2021-03-31 | $1.7M | 31k | 56.62 |
| 2020-12-31 | $2.9M | 36k | 81.46 |
| 2020-09-30 | $2.5M | 35k | 71.24 |
| 2020-06-30 | $3.6M | 44k | 82.29 |
| 2020-03-31 | $2.2M | 38k | 58.82 |
| 2019-12-31 | $3.6M | 35k | 103.37 |
| 2019-09-30 | $644k | 32k | 20.25 |
| 2019-06-30 | $805k | 31k | 25.74 |
| 2017-03-31 | $53k | 14k | 3.87 |